Are you a Knight ADRC affiliated researcher with a news article you would like us to post?
Contact Us
Blood test can predict presence of beta-amyloid in the brain, new study finds (Links to an external site)
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.
How a hyperactive cell in the brain might trigger Alzheimer’s disease (Links to an external site)
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.
Racial equity in Alzheimer’s research focus of $7 million in grants (Links to an external site)
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.
New Alzheimer’s treatment targets identified (Links to an external site)
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.
We May Be Getting Closer to an Alzheimer’s Vaccine (Links to an external site)
A new study shows safety and potential benefit for patients with mild disease. Axon’s experimental vaccine AADVac1—currently the most clinically advanced tau therapy in development—aims to do exactly that. Its goal is to activate our bodies’ defense system to clear out free-floating tau proteins in our brains before they can form harmful tangles that accumulate inside nerve […]